J B Chemicals ties up with Australian firm for development, supply of products

EPP News Bureau - Mumbai

J B Chemicals & Pharmaceuticals Ltd (JBCPL) has recently entered into a development and supply agreement with Pharm-a-Care Laboratories Pty Ltd (Pharm-a-Care), a leading OTC pharmaceutical company in Australia to give further fillip to its fast growing export business. Under the agreement, JBCPL will develop and manufacture niche products including tablets and lozenges in various OTC therapeutic segments particularly the cough, cold and flu area and these products will be exclusively marketed by Pharm-a-Care in Australia, according to a press release. Additionally, JBCPL retains the global rights to market these products in all countries except Australia.

This latest development backed by the company’s strong R&D activities will additionally establish JBCPL’s presence in the vast and fast growing Australian OTC market and further consolidate its strong position in the international markets, the release said. The company’s export for FY 2003-2004 was Rs 162.29 crore, constituting 52 per cent of its turnover. The exports for 2004-05 are likely to be substantially higher.
Commenting on the new deal in Australia, J B Mody - chairman and managing director of JBCPL, said, ‘‘Our development, manufacture and supply agreement with Pharm-a-Care, a leading Australian OTC company continues to show that we are a R&D and manufacturing focused company with the ability to develop innovative quality products. Our lozenges will start to gain acceptance globally. This marks our first entrance into the Australian regulated market.’’